Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study.
BACKGROUND
Dietary flavonoids may protect against cardiovascular disease, but evidence is still conflicting. Tea is the major source of flavonoids in Western populations.


OBJECTIVE
The association of tea and flavonoid intake with incident myocardial infarction was examined in the general Dutch population.


METHODS
A longitudinal analysis was performed with the use of data from the Rotterdam Study-a population-based study of men and women aged >or=55 y. Diet was assessed at baseline (1990-1993) with a validated semiquantitative food-frequency questionnaire. The analysis included 4807 subjects with no history of myocardial infarction, who were followed until 31 December 1997. Data were analyzed in a Cox regression model, with adjustment for age, sex, body mass index, smoking status, pack-years of cigarette smoking, education level, and daily intakes of alcohol, coffee, polyunsaturated fat, saturated fat, fiber, vitamin E, and total energy.


RESULTS
During 5.6 y of follow-up, a total of 146 first myocardial infarctions occurred, 30 of which were fatal. The relative risk (RR) of incident myocardial infarction was lower in tea drinkers with a daily intake >375 mL (RR: 0.57; 95% CI: 0.33, 0.98) than in nontea drinkers. The inverse association with tea drinking was stronger for fatal events (0.30; 0.09, 0.94) than for nonfatal events (0.68; 0.37, 1.26). The intake of dietary flavonoids (quercetin + kaempferol + myricetin) was significantly inversely associated only with fatal myocardial infarction (0.35; 0.13, 0.98) in upper compared with lower tertiles of intake.


CONCLUSIONS
An increased intake of tea and flavonoids may contribute to the primary prevention of ischemic heart disease.
Geleijnse
Johanna M
JM
Department of Epidemiology & Biostatistics, Erasmus Medical Center, Rotterdam, Netherlands.
Launer
Lenore J
LJ
Van der Kuip
Deirdre A M
DA
Hofman
Albert
A
Witteman
Jacqueline C M
JC
D000368:Aged; D004032:Diet; D004305:Dose-Response Relationship, Drug; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D015994:Incidence; D044949:Kaempferols; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D009426:Netherlands; D011794:Quercetin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D018570:Risk Assessment; D013662:Tea
D005419:Flavonoids; D044949:Kaempferols; D013662:Tea; C006552:kaempferol; C040015:myricetin; D011794:Quercetin